- Feature Paper
- Article
Effect of Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia: A Case-Control Cohort Study
- Benjamin Rossi,
- Lee S. Nguyen,
- Philippe Zimmermann,
- Faiza Boucenna,
- Louis Dubret,
- Louise Baucher,
- Helene Guillot,
- Marie-Anne Bouldouyre,
- Yves Allenbach and
- Joe-Elie Salem
- + 3 authors
Tocilizumab, an anti-interleukin-6 receptor, administrated during the right timeframe may be beneficial against coronavirus-disease-2019 (COVID-19) pneumonia. All patients admitted for severe COVID-19 pneumonia (SpO2 ≤ 96% despite O2-support ≥...

